ETF收评：港股创新药ETF基金领跌3.34%
Nan Fang Du Shi Bao·2025-08-19 07:32
Group 1 - The overall performance of ETFs on the 19th showed mixed results, with the communication ETF (515880) leading the gains at 4.04% [2] - The AI-focused ETFs on the ChiNext market, specifically the Guotai (159388) and Southern (159382) funds, also experienced positive growth, rising by 2.67% and 2.55% respectively [2] - Conversely, the Hong Kong innovative drug ETFs faced declines, with the Hong Kong Innovation Drug ETF Fund (520700) dropping by 3.34%, followed closely by the Hong Kong Connect Innovative Drug ETF (520880) at a decrease of 3.28%, and Tianhong's innovative drug ETF (517380) down by 3.25% [2]